Author:
Danne T.,Freckmann G.,Kautzky-Willer A.,Lang U.,Lehmann R.,Pfohl M.,Schloot N. C.,Schumm-Draeger P. M.
Publisher
Springer Berlin Heidelberg
Reference87 articles.
1. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–300
2. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301: 1573–1579
3. Dagan SA, Ziegler AG, Pozzilli PG, Linn T, Schernthaner G, Bonnici F, Elias D, Eren R, Cohen IR, Raz I and Group S (2012) Recent Data from DIA-AID 1, a Global Phase III Clinical Study in Newly Diagnosed Type 1 Diabetes Patients. Diabetes 61 (Suppl 1): 292-OR
4. Eisenbarth GS (2012) Prediction of Type 1A Diabetes. In: Eisenbarth GS (ed) The natural history of the prediabetic period. Type 1 diabetes: cellular, molecular and clinical immunology. Online edition version 3.0.
http://www.ucdenver.edu/academics/colleges/medicalschool/centers/BarbaraDavis/OnlineBooks/Pages/Type1Diabetes.aspx
.4 Zugriff 21 Dez 2013
5. Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA (2013) Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with type 1 diabetes. Biol Blood Marrow Transplant 19: 1126–1129